Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paravertebral Block with Liposomal Bupivacaine vs Continuous Ropivacaine for Postoperative Pain after Thoracoscopic Lobectomy
ChiCTR2600118339Phase 4Completed
- Sponsor
- Huadong Hospital, Fudan University
- Start
- Feb 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine and ropivacaine in postoperative pain (2 arms), sponsored by Huadong Hospital, Fudan University. Primary endpoints: VAS score at rest at 48 hours postoperation, Postoperative white blood cell count and 2 more. Started Feb 2026; status: completed.
02
Drugs
bupivacaineropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600118339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600118339.